Logo


It's time for India's one-brand pharma firms to scale up, diversify

Many of these brands are not protected against the discovery a new, more efficient molecule as the small firms that own them have not kept pace with the latest research

medicine
Representative Image

Some of the biggest winners in the country’s Rs  1.3-trillion drug market come from its smallest firms, family-run businesses with limited financial and marketing heft that have a superbrand in their portfolio. Topical disinfectant Betadine (Win Medicare), anti-cold medicine Sinarest (Centaur Pharma), a tonic relabelled as a nutraceutical, Dexorange (Franco Indian Pharma) and multi-vitamin Zincovit (Apex Lab) among many others are all market leaders with enviable recall, often going head-to-head with large, global pharma brands.  Smart, word-of-mouth marketing aided ...